Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis

Human Immunology

Volumn 72, Issue 5, 2011, Pages 458-461

  Carmona, F David ^a   Rodríguez Rodríguez, Luis ^a,b   Castañeda, Santos ^c   Miranda Filloy, José A ^d   Morado, Inmaculada C ^b   Narváez, Javier ^e   Marí Alfonso, Beatriz ^f   Unzurrunzaga, Ainhoa ^g   Ríos Fernández, Raquel ^h   Blanco, Ricardo ⁱ   de Miguel, Eugenio ^j   Martín, Javier ^a   González Gay, Miguel A ⁱ  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL XERAL CALDE   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

more..

Author keywords

Chemokines; Genetics CCR5 32CCR5 polymorphism; Giant cell arteritis; Temporal artery biopsy

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GENOMIC DNA;

AGED; ARTICLE; BLOOD VESSEL BIOPSY; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; VISUAL DISORDER;

AGED; AGED, 80 AND OVER; BIOPSY; CEREBROVASCULAR DISORDERS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GIANT CELL ARTERITIS; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMYALGIA RHEUMATICA; RECEPTORS, CCR5; SEQUENCE DELETION; SPAIN; TEMPORAL ARTERIES;

EID: 79954616365     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.02.009     Document Type: Article

References (30)

1. Gonzalez-Gay M.A., Vazquez-Rodriguez T.R., Lopez-Diaz M.J., Miranda-Filloy J.A., Gonzalez-Juanatey C., Martin J., et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009, 61:1454-1461.
2. Gonzalez-Gay M.A., Amoli M.M., Garcia-Porrua C., Ollier W.E. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003, 33:38-48.
3. Orozco G., Rueda B., Martin J. Genetic basis of rheumatoid arthritis. Biomed Pharmacother 2006, 60:656-662.
4. Dababneh A., Gonzalez-Gay M.A., Garcia-Porrua C., Hajeer A., Thomson W., Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998, 25:2140-2145.
5. Ward S.G., Marelli-Berg F.M. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem J 2009, 418:13-27.
6. Baggiolini M., Loetscher P. Chemokines in inflammation and immunity. Immunol Today 2000, 21:418-420.
7. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
8. Martens H.A., Kallenberg C.G., Bijl M. Role of CCR5 Delta32 bp deletion in RA and SLE. Autoimmunity 2009, 42:260-262.
9. Gómez-Reino J.J., Pablos J.L., Carreira P.E., Santiago B., Serrano L., Vicario J.L., et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum 1999, 42:989-992.
10. Amoli M.M., Ollier W.E., Gonzalez-Gay M.A. Lack of association of epithelial cell-derived neurophil-activating peptide (ENA)-78 gene polymorphism with susceptibility to biopsy-proven giant cell arteritis. Clin Exp Rheumatol 2007, 25(Suppl 44):S40.
11. Amoli M.M., Salway F., Zeggini E., Ollier W.E., Gonzalez-Gay M.A. MCP-1 gene haplotype association in biopsy proven giant cell arteritis. J Rheumatol 2005, 32:507-510.
12. Makki R.F., al Sharif F., González-Gay M.A., García-Porrúa C., Ollier W.E., Hajeer A.H., et al. Polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin Exp Rheumatol 2000, 18:391-393.
13. Gonzalez-Gay M.A., Garcia-Porrua C., Llorca J., Gonzalez-Louzao C., Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: Clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001, 30:249-256.
14. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.
15. Radstake T.R., Gorlova O., Rueda B., Martin J.E., Alizadeh B.Z., Palomino-Morales R., et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010, 42:426-429.
16. González-Gay M.A., García-Porrúa C., Vázquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998, 25:1750-1755.
17. Gonzalez-Gay M.A., Barros S., Lopez-Diaz M.J., Garcia-Porrua C., Sanchez-Andrade A., Llorca J. Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients. Medicine 2005, 84:269-276.
18. Gonzalez-Gay M.A., Lopez-Diaz M.J., Barros S., Garcia-Porrua C., Sanchez-Andrade A., Paz-Carreira J., et al. Giant cell arteritis: Laboratory tests at the time of diagnosis in a series of 240 patients. Medicine 2005, 84:277-290.
19. Rueda B., Lopez-Nevot M.A., Lopez-Diaz M.J., Garcia-Porrua C., Martin J., Gonzalez-Gay M.A. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 2005, 32:1737-1741.
20. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996, 2:1240-1243.
21. Mueller A., Strange P.G. The chemokine receptor, CCR5. Int J Biochem Cell Biol 2004, 36:35-38.
22. Katschke K.J., Rottman J.B., Ruth J.H., Qin S., Wu L., LaRosa G., et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001, 44:1022-1032.
23. Brühl H., Vielhauer V., Weiss M., Mack M., Schlöndorff D., Segerer S. Expression of DARC, CXCR3 and CCR5 in giant cell arteritis. Rheumatol 2005, 44:309-313.
24. Pokorny V., McQueen F., Yeoman S., Merriman M., Merriman A., Harrison A., et al. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis 2005, 64:487-490.
25. Gonzalez-Gay M.A. Giant cell arteritis and polymyalgia rheumatica: Two different but often overlapping conditions. Semin Arthritis Rheum 2004, 33:289-293.
26. Salvarani C., Boiardi L., Timms J.M., Silvestri T., Ranzi A., Macchioni P.L., et al. Absence of the association with CC chemokine receptor 5 polymorphism in polymyalgia rheumatica. Clin Exp Rheumatol 2000, 18:591-595.
27. Rueda B., Roibas B., Martin J., Gonzalez-Gay M.A. Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. J Rheumatol 2007, 34:1535-1539.
28. Palomino-Morales R.J., Vazquez-Rodriguez T.R., Torres O., Morado I.C., Castañeda S., Miranda-Filloy J.A., et al. Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis. Arthritis Res Ther 2010, 12:R51.
29. Gonzalez-Gay M.A., Hajeer A.H., Dababneh A., Garcia-Porrua C., Mattey D.L., Amoli M.M., et al. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol 2002, 20:179-184.
30. Gonzalez-Gay M.A., Hajeer A.H., Dababneh A., Garcia-Porrua C., Amoli M.M., Llorca J., et al. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol 2004, 22(Suppl 36):S18-S20.